This activity is sponsored by PTCE and supported by an educational grant from Merck Sharpe & Dohme Corp.

Speaker: David DeRemer, PharmD, BCOP, FCCP, FHOPA, HOPA President  

rogram Description 
The COVID-19 pandemic has impacted patients with cancer in multiple ways. Patients with cancer are at a higher risk for contracting COVID-19, and they are also more likely to experience higher morbidity and mortality. The higher risk and mortality present critical challenges for oncology teams who care for and manage these patients. Several organizations have issued cancer-specific guidance for health care providers during the COVID-19 pandemic, and these recommendations continue to evolve quickly based on growing data and supportive evidence. Oncology care teams’ roles have transformed to meet changing practices and challenges. This program will highlight changes to oncology practice and share opportunities to help improve patient outcomes during the pandemic.  

Target Audience: Oncology pharmacists, pharmacy technicians, physicians, and nurses 

Type of Activity: Knowledge 

Educational Objectives: 
At the completion of this activity, pharmacists, physicians, and nurses will be able to: 

•    Recognize the impact that COVID-19 has had on the treatment and management of patients with cancer

•    Discuss the evolving guidelines and recommendations for cancer treatment during the COVID-19 pandemic

•    Outline strategies for the oncology care team that improve disease- and treatment-related management in patients with cancer during the COVID-      

     19 pandemic

At the completion of this activity pharmacy technicians will be able to: 

•    Recognize the impact that COVID-19 has had on the treatment and management of patients with cancer

•    Discuss the evolving guidelines and recommendations for cancer treatment during the COVID-19 pandemic

•    Identify operational tactics to improve management of patients with cancer during the COVID-19 pandemic

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (1.0 CEU) under the ACPE universal activity numbers 0290-0000-20-259-L01-P and 0290-0000-20-259-L01-T. The activity is available for CE credit on October 23, 2020.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education 
(ACCME) through the joint providership of Physicians’ Education Resource®, LLC and Pharmacy Times Continuing Education™. Physicians’ Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this live activity for a maximum of 3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 3 Contact Hours. Instructions for Completing the Activity and Receiving CPE Credit to receive CPE credit, participants must complete the pretest, view the webcast in its entirety, complete the posttest, and complete the online activity evaluation.

After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. Credit must be requested no later than December 23, 2020. CE credit will not be issued after this date.